CMS To Update Senate Finance Cmte. On Medicare Rx Rules
This article was originally published in The Pink Sheet Daily
Committee's Sept. 14 hearing also includes testimony from PCMA, AHIP and Business Roundtable. Issues that could be discussed include USP's proposed drug classification system for Medicare and boundaries for health plan coverage.
You may also be interested in...
CMS will set up a Part D bidding system that will get to the highest level of risk that the market will accept, Administrator McClellan says. "Smaller regions" could encourage drug plan sponsors that are unwilling to take on large capacity, he says.
Ag/FDA subcommittee had tabled FDA hearing pending confirmation of a permanent agency commissioner. House cleared FDA 2006 spending in early June.
Amgen, J&J, Sanofi-Aventis, Pfizer, Merck, Roche, Lilly and Schering-Plough are scheduled to report results in upcoming week. Bristol could expand upon plans to sell OTC unit to Novartis the following week.